Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

2020/03/25 by Saiju Jacob, Srikanth Muppidi, Amanda C. Guidon +13 · 27 citations
Medicine · #Myasthenia Gravis and Thymoma #Long-Term Effects of COVID-19

paper · pdf · doi:10.1016/j.jns.2020.116803

Cited by

• The Influence of Loneliness and Anxiety Levels on MG-Specific Quality of Life in Patients with Myasthenia Gravis during the COVID-19 Pandemic
• Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study
• Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network. [europepmc]
• COVID-19 in patients with myasthenia gravis. [europepmc]
• Myasthenic crisis in COVID-19. [europepmc]
• Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: Challenges and opportunities. [europepmc]
• The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. [europepmc]
• Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. [europepmc]
• COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome. [europepmc]
• COVID-19 and generalized Myasthenia Gravis exacerbation: A case report. [europepmc]
• Neurological immunotherapy in the era of COVID-19 - looking for consensus in the literature. [europepmc]
• Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium. [europepmc]
• Description of 3 patients with myasthenia gravis and COVID-19. [europepmc]
• Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic. [europepmc]
• Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase. [europepmc]
• Neurological consequences of COVID-19: what have we learned and where do we go from here? [europepmc]
• Association between autoimmune diseases and COVID-19 as assessed in both a test-negative case-control and population case-control design. [europepmc]
• Postinfectious Onset of Myasthenia Gravis in a COVID-19 Patient. [europepmc]
• COVID-19-associated risks and effects in myasthenia gravis (CARE-MG). [europepmc]
• Peripheral Nervous System Manifestations Associated with COVID-19. [europepmc]
• Neurological Complications of COVID-19: Underlying Mechanisms and Management. [europepmc]
• COVID-19 in patients with myasthenia gravis: Epidemiology and disease course. [europepmc]
• Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival. [europepmc]
• Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic. [europepmc]
• A Case of COVID-19 Vaccine Causing a Myasthenia Gravis Crisis. [europepmc]
• Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: A multicenter experience. [europepmc]
• The relationship between myasthenia gravis and COVID-19: a systematic review. [europepmc]